SES implantation may offer a promising therapeutic alternative to PTA for treatment of infrapopliteal peripheral arterial disease.

PCB angioplasty improves patency after angioplasty of venous stenoses of failing vascular access used for dialysis.

The embolism phenomenon during infra-aortic interventions is frequent and underestimated. The liberated particles consisted primarily of atheromatous plaque elements and thrombus. The reported data might support the application of a protective filter basket in selected subsets of lesions with a riskier embolic profile and whenever declotting procedures are performed.

No abstract

ࡗ ࡗPurpose: To report the 6-month angiographic results from a prospective single-center study investigating the efficacy and outcome of sirolimus-eluting stents used for bailout after infrapopliteal revascularization of patients with critical limb ischemia (CLI Results: Hyperlipidemia and symptomatic cardiac and carotid diseases were more pronounced in group S (pϽ0.05). Technical success was 96.6% (28/29 limbs) in group B versus 100.0% in group S (pϭ0.16). Six-month primary patency was 68.1% in group B versus 92.0% in group S (pϽ0.002). Binary in-stent and in-segment restenosis rates were 55.3% and 66.0%, respectively, in patients with bare stents versus 4.0% and 32.0%, respectively, in patients treated with the sirolimus-eluting stents (both pϽ0.001). The target lesion reintervention rate at 6 months was 17.0% in group B versus 4.0% in group S (pϭ0.02). Limb salvage was 100% in both groups. Six-month mortality and minor amputation rates were 6.9% and 17.2%, respectively, in group B versus 10.3% and 3.4%, respectively, in group S (pϭ0.32 and pϭ0.04, respectively). Conclusions: Sirolimus-eluting stents seem to restrict neointimal hyperplasia in the infrapopliteal vascular bed. J Endovasc Ther 2005;12:685-695

No abstract

No abstract

No abstract